Enrico Martin

272 Chapter 11 15. Jones KB, Ferguson PC, Deheshi B, et al. Complete femoral nerve resection with soft tissue sarcoma: functional outcomes. Ann Surg Oncol . 2010;17(2):401-406. doi:10.1245/s10434-009-0745-5 16. Alamanda VK, Crosby SN, Archer KR, Song Y, Schwartz HS, Holt GE. Amputation for extremity soft tissue sarcoma does not increase overall survival: a retrospective cohort study. Eur J Surg Oncol . 2012;38(12):1178-1183. doi:10.1016/j. ejso.2012.08.024 17. Ghert MA, Abudu A, Driver N, et al. The indications for and the prognostic significance of amputation as the primary surgical procedure for localized soft tissue sarcoma of the extremity. Ann Surg Oncol . 2005;12(1):10-17. doi:10.1007/s10434-004- 1171-3 18. Casali PG, Abecassis N, Aro HT, et al. Soft tissue and visceral sarcomas: ESMO- EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow- up. Ann Oncol Off J Eur Soc Med Oncol . 2018;29(Suppl 4):iv51-iv67. doi:10.1093/ annonc/mdy096 19. Ferner RE, Gutmann DH. International consensus statement on malignant peripheral ner ve sheath tumors in neurofibromatosis. Cancer Res . 2002;62(5):1573-1577. 20. Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys . 1998;42(2):351-360. 21. Zehou O, Fabre E, Zelek L, et al. Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review. Orphanet J Rare Dis . 2013;8:127. doi:10.1186/1750-1172-8-127 22. Gerrand CH, Wunder JS, Kandel RA, et al. Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. J Bone Joint Surg Br . 2001;83(8):1149-1155. 23. Clarkson PW, Griffin AM, Catton CN, et al. Epineural dissection is a safe technique that facilitates limb salvage surgery. Clin Orthop Relat Res . 2005;438:92-96. 24. Stucky C-CH, Johnson KN, Gray RJ, et al. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol . 2012;19(3):878-885. doi:10.1245/s10434-011-1978-7 25. Martin E, Slooff W-BM, van Houdt WJ, van Dalen T, Verhoef C, Coert JH. Oncological Treatment Considerations Differ across Surgical Subspecialties Treating Malignant Peripheral Nerve Sheath Tumors: An International Survey. Sarcoma . 2020;2020:6406439. doi:10.1155/2020/6406439 26. Martin E, Coert JH, Flucke UE, et al. Neurofibromatosis-associated malignant peripheral nerve sheath tumors in children have a worse prognosis: A nationwide cohort study. Pediatr Blood Cancer . December 2019:e28138. doi:10.1002/pbc.28138 27. van Noesel MM, Orbach D, Brennan B, et al. Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study. Pediatr Blood Cancer . 2019;66(10):e27833. doi:10.1002 / pbc.27833 28. Dunn GP, Spiliopoulos K, Plotkin SR, et al. Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis Type 1: Clinical article. J Neurosurg . 2013;118(1):142-148. doi:10.3171/2012.9.JNS101610 29. Nambisan RN, Rao U, Moore R, Karakousis CP. Malignant soft tissue tumors of nerve sheath origin. J Surg Oncol . 1984;25(4):268- 272. 30. Melendez M, Brandt K, Evans GR. Sciatic nerve reconstruction: limb preservation after sarcoma resection. Ann Plast Surg . 2001;46(4):375-381.